HK Stock MarketDetailed Quotes

SINGASIA HLDG (08293)

Watchlist
  • 0.270
  • 0.0000.00%
Market Closed Apr 30 09:20 CST
58.06MMarket Cap45.00P/E (TTM)

SINGASIA HLDG (08293) Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jan 31, 2026
(FY)Jul 31, 2025
(Q6)Jan 31, 2025
(FY)Jul 31, 2024
(Q6)Jan 31, 2024
(FY)Jul 31, 2023
(Q6)Jan 31, 2023
(FY)Jul 31, 2022
(Q6)Jan 31, 2022
(FY)Jul 31, 2021
Cash flow from operating activities
Earning before tax
----
76.12%-781.06K
----
-590.82%-3.27M
----
138.42%666.28K
----
-28.99%-1.73M
-80.91%-938.92K
-37.78%-1.34M
Profit adjustment
Attributable subsidiary (profit) loss
----
-178.87%-29.76K
----
1,008.72%37.74K
----
-243.51%-4.15K
----
---1.21K
----
----
Impairment and provisions:
----
-106.73%-135.02K
----
14,840.40%2.01M
----
-72.35%13.43K
----
841.90%48.57K
105.09%420
-100.70%-6.55K
-Impairment of trade receivables (reversal)
----
-96.89%4.98K
----
--160K
----
----
----
841.90%48.57K
----
-114.45%-6.55K
-Other impairments and provisions
----
-107.58%-140K
----
13,649.20%1.85M
----
--13.43K
----
----
105.09%420
----
Revaluation surplus:
----
---1.47M
----
----
----
----
----
----
----
----
-Other fair value changes
----
---1.47M
----
----
----
----
----
----
----
----
Asset sale loss (gain):
----
175.33%85.23K
----
46.99%-113.14K
----
---213.43K
----
----
----
----
-Loss (gain) from sale of subsidiary company
----
175.33%85.23K
----
46.99%-113.14K
----
---213.43K
----
----
----
----
Depreciation and amortization:
----
66.16%588.35K
----
-20.10%354.08K
----
-33.67%443.15K
----
7.00%668.14K
17.53%352.86K
-7.74%624.46K
Financial expense
----
-55.78%88K
----
98.94%199K
----
35.19%100.03K
----
-17.08%73.99K
-25.57%35.42K
72.64%89.23K
Special items
----
----
----
--179.38K
----
----
----
--7.09K
----
----
Operating profit before the change of operating capital
----
-173.11%-1.66M
----
-160.32%-606.42K
----
207.21%1.01M
----
-47.12%-937.69K
-208.59%-550.22K
-192.88%-637.36K
Change of operating capital
Accounts receivable (increase)decrease
----
-320.68%-2.93M
----
328.63%1.33M
----
119.26%309.29K
----
-465.01%-1.61M
-351.49%-629.72K
-78.96%439.87K
Accounts payable increase (decrease)
----
628.19%2.76M
----
-198.40%-522.34K
----
50.94%530.85K
----
299.64%351.68K
2,369.82%926.2K
87.07%-176.16K
prepayments (increase)decrease
----
242.22%357.1K
----
-962.48%-251.09K
----
-68.90%29.11K
----
281.93%93.61K
-2,974.24%-965.77K
-109.07%-51.45K
Special items for working capital changes
----
-62.42%106.97K
----
212.95%284.64K
----
35.01%-252K
----
-352.47%-387.77K
-274.10%-128.65K
33.96%153.59K
Cash  from business operations
----
-689.48%-1.36M
----
-85.79%230.51K
----
165.27%1.62M
----
-815.53%-2.49M
-1,071.42%-1.35M
-112.95%-271.51K
Other taxs
----
193.35%94.53K
----
-713.23%-101.26K
----
65.37%16.51K
----
181.39%9.99K
1,047.94%10.11K
61.50%-12.27K
Special items of business
-6.07%-1.54M
----
-262.22%-1.45M
----
-189.96%-400.67K
----
--445.38K
----
----
----
Net cash from operations
-6.07%-1.54M
-1,078.13%-1.26M
-262.22%-1.45M
-92.11%129.25K
-189.96%-400.67K
166.20%1.64M
133.29%445.38K
-772.43%-2.48M
-1,071.60%-1.34M
-113.74%-283.78K
Cash flow from investment activities
Purchase of fixed assets
----
-50.65%-541.73K
----
-999.93%-359.6K
----
10.55%-32.69K
----
-348.62%-36.55K
---26.27K
97.83%-8.15K
Sale of subsidiaries
----
-4,463.93%-139.43K
----
66.34%-3.06K
----
---9.08K
----
----
----
----
Acquisition of subsidiaries
----
--572
----
----
----
----
----
----
----
----
Cash on investment
----
---186.77K
----
----
----
----
----
----
----
----
Other items in the investment business
480.76%1.32M
----
-133.56%-346K
----
4,358.36%1.03M
----
---24.21K
----
----
----
Net cash from investment operations
480.76%1.32M
-139.17%-867.36K
-133.56%-346K
-768.24%-362.66K
4,358.36%1.03M
-14.28%-41.77K
7.82%-24.21K
-348.62%-36.55K
---26.27K
97.83%-8.15K
Net cash before financing
87.65%-221.99K
-813.29%-2.13M
-385.10%-1.8M
-114.61%-233.4K
49.68%630.41K
163.58%1.6M
130.87%421.16K
-760.61%-2.51M
-1,090.68%-1.36M
-117.27%-291.93K
Cash flow from financing activities
New borrowing
----
339.67%2.75M
----
-12.94%625.86K
----
-64.37%718.91K
----
-37.76%2.02M
-37.12%1.08M
-39.35%3.24M
Refund
----
-220.63%-2.63M
----
-48.45%-819.99K
----
72.94%-552.36K
----
43.25%-2.04M
27.88%-1.29M
43.96%-3.6M
Issuing shares
----
----
----
--2.47M
----
----
----
----
----
----
Issuance of bonds
----
----
----
--1.03M
----
----
----
----
----
----
Interest paid - financing
----
14.03%-72.68K
----
12.74%-84.54K
----
-77.98%-96.89K
----
27.66%-54.44K
29.42%-28.38K
-149.47%-75.25K
Issuance expenses and redemption of securities expenses
----
-770.14%-1.11M
----
---127.12K
----
----
----
----
----
----
Other items of the financing business
107.02%91.52K
----
-131,576.41%-1.3M
----
-98.97%992
----
--95.88K
----
----
----
Net cash from financing operations
107.02%91.52K
-149.23%-1.39M
-131,576.41%-1.3M
975.17%2.83M
-98.97%992
46.85%-323.23K
119.41%95.88K
22.63%-608.17K
-83.90%-493.92K
-196.89%-786.04K
Effect of rate
-56.36%10.37K
1,245.64%11.57K
-27.81%23.76K
-107.21%-1.01K
158.95%32.92K
2,263.99%14K
1,411.41%12.71K
-170.71%-647
39.70%841
498.04%915
Net Cash
95.79%-130.47K
-235.79%-3.52M
-591.21%-3.1M
103.71%2.6M
22.12%631.4K
140.83%1.27M
127.82%517.05K
-189.48%-3.12M
-1,320.05%-1.86M
-143.10%-1.08M
Begining period cash
-84.57%640.9K
166.39%4.15M
166.39%4.15M
475.04%1.56M
475.04%1.56M
-92.01%271.15K
-92.01%271.15K
-24.10%3.39M
-24.10%3.39M
127.11%4.47M
Cash at the end
-51.59%520.8K
-84.57%640.9K
-51.61%1.08M
166.39%4.15M
177.63%2.22M
475.04%1.56M
-47.82%800.9K
-92.01%271.15K
-64.63%1.53M
-24.10%3.39M
Cash balance analysis
Cash and bank balance
-51.59%520.8K
----
--1.08M
----
----
----
----
----
----
----
Currency Unit
SGD
SGD
SGD
SGD
SGD
SGD
SGD
SGD
SGD
SGD
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
--
--
Unqualified Opinion
Auditor
--
Changqing (Hong Kong) Certified Public Accountants Limited
--
Changqing (Hong Kong) Certified Public Accountants Limited
--
Changqing (Hong Kong) Certified Public Accountants Limited
--
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
(Q6)Jan 31, 2026(FY)Jul 31, 2025(Q6)Jan 31, 2025(FY)Jul 31, 2024(Q6)Jan 31, 2024(FY)Jul 31, 2023(Q6)Jan 31, 2023(FY)Jul 31, 2022(Q6)Jan 31, 2022(FY)Jul 31, 2021
Cash flow from operating activities
Earning before tax ----76.12%-781.06K-----590.82%-3.27M----138.42%666.28K-----28.99%-1.73M-80.91%-938.92K-37.78%-1.34M
Profit adjustment
Attributable subsidiary (profit) loss -----178.87%-29.76K----1,008.72%37.74K-----243.51%-4.15K-------1.21K--------
Impairment and provisions: -----106.73%-135.02K----14,840.40%2.01M-----72.35%13.43K----841.90%48.57K105.09%420-100.70%-6.55K
-Impairment of trade receivables (reversal) -----96.89%4.98K------160K------------841.90%48.57K-----114.45%-6.55K
-Other impairments and provisions -----107.58%-140K----13,649.20%1.85M------13.43K--------105.09%420----
Revaluation surplus: -------1.47M--------------------------------
-Other fair value changes -------1.47M--------------------------------
Asset sale loss (gain): ----175.33%85.23K----46.99%-113.14K-------213.43K----------------
-Loss (gain) from sale of subsidiary company ----175.33%85.23K----46.99%-113.14K-------213.43K----------------
Depreciation and amortization: ----66.16%588.35K-----20.10%354.08K-----33.67%443.15K----7.00%668.14K17.53%352.86K-7.74%624.46K
Financial expense -----55.78%88K----98.94%199K----35.19%100.03K-----17.08%73.99K-25.57%35.42K72.64%89.23K
Special items --------------179.38K--------------7.09K--------
Operating profit before the change of operating capital -----173.11%-1.66M-----160.32%-606.42K----207.21%1.01M-----47.12%-937.69K-208.59%-550.22K-192.88%-637.36K
Change of operating capital
Accounts receivable (increase)decrease -----320.68%-2.93M----328.63%1.33M----119.26%309.29K-----465.01%-1.61M-351.49%-629.72K-78.96%439.87K
Accounts payable increase (decrease) ----628.19%2.76M-----198.40%-522.34K----50.94%530.85K----299.64%351.68K2,369.82%926.2K87.07%-176.16K
prepayments (increase)decrease ----242.22%357.1K-----962.48%-251.09K-----68.90%29.11K----281.93%93.61K-2,974.24%-965.77K-109.07%-51.45K
Special items for working capital changes -----62.42%106.97K----212.95%284.64K----35.01%-252K-----352.47%-387.77K-274.10%-128.65K33.96%153.59K
Cash  from business operations -----689.48%-1.36M-----85.79%230.51K----165.27%1.62M-----815.53%-2.49M-1,071.42%-1.35M-112.95%-271.51K
Other taxs ----193.35%94.53K-----713.23%-101.26K----65.37%16.51K----181.39%9.99K1,047.94%10.11K61.50%-12.27K
Special items of business -6.07%-1.54M-----262.22%-1.45M-----189.96%-400.67K------445.38K------------
Net cash from operations -6.07%-1.54M-1,078.13%-1.26M-262.22%-1.45M-92.11%129.25K-189.96%-400.67K166.20%1.64M133.29%445.38K-772.43%-2.48M-1,071.60%-1.34M-113.74%-283.78K
Cash flow from investment activities
Purchase of fixed assets -----50.65%-541.73K-----999.93%-359.6K----10.55%-32.69K-----348.62%-36.55K---26.27K97.83%-8.15K
Sale of subsidiaries -----4,463.93%-139.43K----66.34%-3.06K-------9.08K----------------
Acquisition of subsidiaries ------572--------------------------------
Cash on investment -------186.77K--------------------------------
Other items in the investment business 480.76%1.32M-----133.56%-346K----4,358.36%1.03M-------24.21K------------
Net cash from investment operations 480.76%1.32M-139.17%-867.36K-133.56%-346K-768.24%-362.66K4,358.36%1.03M-14.28%-41.77K7.82%-24.21K-348.62%-36.55K---26.27K97.83%-8.15K
Net cash before financing 87.65%-221.99K-813.29%-2.13M-385.10%-1.8M-114.61%-233.4K49.68%630.41K163.58%1.6M130.87%421.16K-760.61%-2.51M-1,090.68%-1.36M-117.27%-291.93K
Cash flow from financing activities
New borrowing ----339.67%2.75M-----12.94%625.86K-----64.37%718.91K-----37.76%2.02M-37.12%1.08M-39.35%3.24M
Refund -----220.63%-2.63M-----48.45%-819.99K----72.94%-552.36K----43.25%-2.04M27.88%-1.29M43.96%-3.6M
Issuing shares --------------2.47M------------------------
Issuance of bonds --------------1.03M------------------------
Interest paid - financing ----14.03%-72.68K----12.74%-84.54K-----77.98%-96.89K----27.66%-54.44K29.42%-28.38K-149.47%-75.25K
Issuance expenses and redemption of securities expenses -----770.14%-1.11M-------127.12K------------------------
Other items of the financing business 107.02%91.52K-----131,576.41%-1.3M-----98.97%992------95.88K------------
Net cash from financing operations 107.02%91.52K-149.23%-1.39M-131,576.41%-1.3M975.17%2.83M-98.97%99246.85%-323.23K119.41%95.88K22.63%-608.17K-83.90%-493.92K-196.89%-786.04K
Effect of rate -56.36%10.37K1,245.64%11.57K-27.81%23.76K-107.21%-1.01K158.95%32.92K2,263.99%14K1,411.41%12.71K-170.71%-64739.70%841498.04%915
Net Cash 95.79%-130.47K-235.79%-3.52M-591.21%-3.1M103.71%2.6M22.12%631.4K140.83%1.27M127.82%517.05K-189.48%-3.12M-1,320.05%-1.86M-143.10%-1.08M
Begining period cash -84.57%640.9K166.39%4.15M166.39%4.15M475.04%1.56M475.04%1.56M-92.01%271.15K-92.01%271.15K-24.10%3.39M-24.10%3.39M127.11%4.47M
Cash at the end -51.59%520.8K-84.57%640.9K-51.61%1.08M166.39%4.15M177.63%2.22M475.04%1.56M-47.82%800.9K-92.01%271.15K-64.63%1.53M-24.10%3.39M
Cash balance analysis
Cash and bank balance -51.59%520.8K------1.08M----------------------------
Currency Unit SGDSGDSGDSGDSGDSGDSGDSGDSGDSGD
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion--Unqualified Opinion------Unqualified Opinion
Auditor --Changqing (Hong Kong) Certified Public Accountants Limited--Changqing (Hong Kong) Certified Public Accountants Limited--Changqing (Hong Kong) Certified Public Accountants Limited--National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More